Clinical Trial Update: L-Arginine and Sickle Cell Disease [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating L-Arginine for sickle cell disease. The trial was sponsored by Hospital de Clinicas …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Sickle Cell Disease | Phase 3 | Status: COMPLETED